Contribution of cytochrome P450 3A pathway to bromocriptine metabolism and effects of ferrous iron and hypoxia-re-oxygenation on its elimination in the perfused rat liver

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 5, 1997, Pages 551-557

  Matsubayashi, Keiko ^a   Matsumoto, Hiroshi ^a   Fukui, Yuko ^a  

^a KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CYTOCHROME P450; FERROUS ION; FREE RADICAL; TROLEANDOMYCIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG ELIMINATION; DRUG METABOLISM; HYPOXIA; LIVER PERFUSION; MALE; NONHUMAN; RAT; REOXYGENATION;

EID: 0030916427     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06840.x     Document Type: Article

References (35)

1. Ball, S. E., Maurer, G., Zollinger, M., Ladona, M., Vickers, A. E. M. (1992) Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of ergot alkaloid CQA 206-291 in humans. Drug. Metab. Dispos. 20: 56-63
2. Berthou, F., Dreano, Y., Be;;oc, C., Kangas, L., Gautier, J. H., Beaune, P. (1994) Involvement of cytochrome P450 3A enzyme family in the major metabolic pathway of toremifene in human liver microsomes. Biochem. Pharmacol. 47: 1883-1895
3. Braughler, J. M., Duncan, L. A., Chase, R. L. (1986) The involvement of iron in lipid peroxidation. J. Biol. Chem. 261: 10282-10289
4. Brissot, P., Wright, T. L., Ma, W. L., Weisiger, R. A. (1985) Efficient clearance of non-transferrin-bound iron by rat liver: implications for hepatic iron loading in iron overload states. J. Clin. Invest. 76: 1463-1470
5. Bucher, J. R., Tien, M., Aust, S. D. (1983) The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron. Biochem. Biophys. Res. Commun. 111: 777-784
6. Bysani, G. K., Kennedy, T. P., Ky, N., Rao, N. V., Blaze, C. A., Hoidal, J. R. (1990) Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J. Clin. Invest. 86: 1434-1441
7. Caraceni, P., Gasbarrini, A., Nussler, A., Silvio, M. D., Bartoli, F., Borle, A. B., Thiel, D. H. V. (1994) Human hepatocytes are more resistant than rat hepatocytes to anoxia - re-oxygenation injury. Hepatology 20: 1247-1254
8. Chang, T. K. H., Gonzalez, F. J., Waxman, D., J. (1994) Evaluation of triacetyloleandomycin, -naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes p450. Arch. Biochem. Biophys. 311: 437-442
9. Chou, C. H., Evans, A. M., Fornasini, G., Rowland, M. (1993) Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver. Drug. Metab. Dispos. 21: 933-938
10. Coon, M. J., Ding, X., Pernecky, S. J., Vaz, A. D. N. (1992) Cytochrome P450: progress and predictions. FASEB. J. 6: 669-673
11. Evans, A. M., Hussein, Z., Rowland, M. (1991) A two-compartment dispersion model describes the hepatic outflow profile of diclofenac in the presence of its binding protein. J. Pharm. Pharmacol. 43: 709-714
12. Gores, G. J., Kost, L. J., LaRusso, N. F. (1986) The isolated perfused rat liver: conceptual and practical considerations. Hepatology 6: 511-517
13. Hijioka, T., Sato, N., Matsumura, H., Yoshihara, Y., Takei, H., Oshita, S., Kawano, S., Kamada, T. (1991) Ethanol-induced disturbance of hepatic microcirculation and hepatic hypoxia. Biochem. Pharmacol. 41: 1551-1557
14. Larsen, N. E., Öhman, R., Larsson, M., Hvidberg, E. F. (1979) Determination of bromocriptine in plasma: comparison of gas chromatography, mass fragmentography and liquid chromatography. J. Chromatogr. 174: 341-349
15. Littauer, A., Groot, H. D. (1992) Release of reactive oxygen hepatocytes on re-oxygenation: three phases and role of mitochondria. Am. J. Physiol. 262: G1015-G1020
16. Matsumoto, H., Matsubayashi, K., Fukui, Y. (1994) Estimation of ethanol first-pass effect in the perfused rat liver. Alcohol Alcohol. 29(Suppl 1): 9-13
17. Matsumoto, H., Matsubayashi, K., Fukui, Y. (1996) Evidence that cytochrome P-450 2E1 contributes to ethanol elimination at low dose: effects of diallyl sulfide and 4-methyl pyrazole on ethanol elimination in the perfused rat liver. Alcohol Clin. Exp. Res. 20: 12A-16A
18. Maurer, G., Schreier, E., Delaborde, S., Nufer, R., Shukla, A. P. (1983) Fate and disposition of bromocriptine in animals and man II: absorption, elimination and metabolism. Eur. J. Drug. Metab. Pharmacokin. 8: 51-62
19. Moochhala, S. M., Lee, E. J. D., Hu, G. T. M., Koh, O. S., Becket, G. (1989) Effect of bromocriptine on hepatic cytochrome P-450 monooxygenase system. Jpn J. Pharmacol. 49: 285-291
20. Ogawa, N. (1994) Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages. Eur. Neurol. 34 (suppl. 3): 20-28
21. Paller, M. S., Jacob, H. S. (1994) Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during re-oxygenation of the kidney. Proc. Natl Acad. Sci. USA 91: 7002-7006
22. Peyronneau, M. A., Delaforge, M., Riviere, R., Renaud, J. P., Mansuy, D. (1994) High affinity of ergopeptides for cytochromes p450 3A: importance of their peptide moiety for p-450 recognition and hydroxylation of bromocriptine. Eur. J. Biochem. 223: 947-956
23. Roberts, M. S., Rowland, M. (1986) A dispersion model of hepatic elimination. 1. Formulation of the model and bolus considerations. J. Pharmacokinet. Biopharm. 14: 227-260
24. Schran, H. F., Bhuta, S. I., Schwarz, H. J., Thorner, M. O. (1980) The pharmacokinetics of bromocriptine in man. In: Goldstein, M., Calne, D. B., Lieberman, A., Thorner, M. O. (eds) Ergot Compounds and Brain Function. Neuroendocrine and Neuropsychiatric Aspects. Raven Press, New York, pp 125-139
25. Schran, H. F., Tse, F. L. S., Bhuta, S. I. (1985) Pharmacokinetics and pharmacodynamics of bromocriptine in the rat. Biopharm. Drug. Dispos. 6: 301-311
26. White, R. E. (1991) The involvement of free radicals in the mechanisms of monooxygenases. Pharmacol. Ther. 49: 21-42
27. Williams, R. N., Delamere, N. A., Paterson, C. A. (1985) Inactivation of catalase with 3-amino-1,2,4-triazole: an indirect irreversible mechanism. Biochem. Pharmacol. 34: 3386-3389
28. Wright, T. L., Brissot, P., Ma, W. L., Weisiger, R. A. (1986) Characterization of non-transferrin-bound iron clearance by rat liver. J. Biol. Chem. 261: 10909-10914
29. Yamaoka, K., Nakagawa, T., Uno, T. (1978a) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6: 165-175
30. Yamaoka, K., Nakagawa, T., Uno, T. (1978b) Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6: 547-558
31. Yano, Y., Yamaoka, K., Aoyama, Y., Tanaka, H. (1989) Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT). J. Pharmacokinet. Biopharm. 17: 179-202
32. Yano, Y., Yamaoka, K., Minamide, T., Nakagawa, T., Tanaka, H. (1990) Evaluation of protein binding effect on local disposition of oxacillin in rat liver by a two-compartment dispersion model. J. Pharm. Pharmacol. 42: 632-636
33. Yasui, H., Yamaoka, K., Fukuyama, T., Nakagawa, T. (1995) Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index. Drug. Metab. Dispos. 23: 779-785
34. Yoshikawa, T., Minamikawa, Y., Naito, Y., Kondo, M. (1994) Anti-oxidant properties of bromocriptine, a dopamine agonist. J. Neurochem. 62: 1034-1038
35. Younes, M., Kayser, E., Strubelt, O. (1992) Effect of antioxidants on hypoxia/re-oxygenation-induced injury isolated perfused rat liver. Pharmacol. Toxicol. 71: 278-283